BioPharmaceutical Business Intelligence

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Drug patents in 130+ countries

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

US Army
Johnson and Johnson
Chinese Patent Office

Generated: December 12, 2017

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 040905

« Back to Dashboard

NDA 040905 describes KALEXATE, which is a drug marketed by Kvk Tech and is included in one NDA. It is available from four suppliers. Additional details are available on the KALEXATE profile page.

The generic ingredient in KALEXATE is sodium polystyrene sulfonate. There are one thousand four hundred drug master file entries for this compound. Eighteen suppliers are listed for this compound. Additional details are available on the sodium polystyrene sulfonate profile page.

Summary for 040905

Therapeutic Class:Antidotes, Deterrents, and Toxicologic Agents
Formulation / Manufacturing:see details

Suppliers and Packaging for NDA: 040905

Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
KALEXATE sodium polystyrene sulfonate POWDER;ORAL, RECTAL 040905 ANDA Major Pharmaceuticals 0904-6041 0904-6041-27 454 g in 1 BOTTLE (0904-6041-27)
KALEXATE sodium polystyrene sulfonate POWDER;ORAL, RECTAL 040905 ANDA KVK-Tech, Inc. 10702-036 10702-036-15 15 g in 1 BOTTLE (10702-036-15)

Summary for product number 001

Active Rx/OTC/Discontinued:RXDosage:POWDER;ORAL, RECTALStrength454GM/BOT
Approval Date:Mar 30, 2009TE:AARLD:No

Summary for product number 002

Active Rx/OTC/Discontinued:RXDosage:POWDER;ORAL, RECTALStrength15GM/BOT
Approval Date:Apr 3, 2015TE:RLD:No

Complete Access Available with Subscription
« Back to Dashboard

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

US Department of Justice
Farmers Insurance
Cantor Fitzgerald

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch: